United States· US:73590-0073_4c2a01bc-c624-4feb-a024-e83aa1a5fefe
COXIR INTENSIVE EGF PEPTIDE SERUM
A medicinal product containing niacinamide; adenosine, registered in United States by NOKSIBCHO cosmetic Co., Ltd..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NIACINAMIDE; ADENOSINE
- Manufacturer
- NOKSIBCHO cosmetic Co., Ltd.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1173590007321 CONTAINER in 1 CARTON (73590-0073-2) / 50 mL in 1 CONTAINER (73590-0073-1)
- ndc1173590-0073-2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ca80f2fd-a89d-4582-bc75-bef607ab3e4d GET /v1/drugs/ca80f2fd-a89d-4582-bc75-bef607ab3e4d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "1; .02",
"substance": "NIACINAMIDE; ADENOSINE",
"productndc": "73590-0073",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "g/50mL; g/50mL",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about niacinamide; adenosine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.